Tumor cell-derived IL-1α has been linked with higher metastasis in lung cancer and breast cancer, indicating potential therapeutic value for blocking the IL-1α/IL1R/MyD88/TET2 axis (65, 66). Here, IL1A is linked to lung carcinoma.